References
- Ashton R. E., Millward-Sadler G. H., White J. E. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis. J Invest Dermatol 1982; 79: 229–232
- Dahl M. G., Gregory M. M., Scheuer P. J. Methotrexate hepatotoxicity in psoriasis: comparison of different dose regimes. BMJ 1972; 1: 654–656
- Podurgiel B. J., McGill D. B., Ludwig J., Taylor W. F., Muller S. A. liver injury associated with methotrexate therapy for psoriasis. Mayo Clin Proc 1973; 48: 787–792
- Millward-Sadler G. H., Ryan T. J. Methotrexate induced liver disease in psoriasis. Br J Dermatol 1974; 90: 661–667
- Kremer J. M., Lee R. G., Tolman K. G. Liver histology in rheumatoid arthritis patients receiving long‐term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis‐Rheum 1989; 32: 121–127
- Mitchell D., Smith A., Rowan B., et al. Serum type HJ procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate. Br J Dermatol 1990; 122: 1–7
- Arias J. M., Morton K. A., Albro J. E., et al. Comparison of methods for identifying early methotrexate‐induced hepatotoxicity in patients with rheumatoid arthritis. J Nucl Med 1993; 34: 1905–1909
- Millward-Sadler G. H., Whorwell P. J. Liver biopsy: methods, diagnostic value and interpretation. Wright's Liver and Biliary Disease, Millward-Sadler, et al. Saunders Co, Philadelphia 1992; 476–497
- Minocha A., Dean H. A., Pittsley R. A. Liver cirrhosis in rheumatoid arthritis patients treated with long‐term methotrexate. Vet Hum Toxicol 1993; 35: 45–48
- Nohlgard C., Rubio C. A., Kock Y., Hammar H. Liver fibrosis quantified by image analysis in methotrexate‐treated patients with psoriasis. J Am Acad Dermatol 1993; 28: 40–45
- Themido R., Loureiro M., Pecegueiro M., Brandao M., Campos M. C. Methotrexate hepatotoxicity in psoriatic patients submitted to long‐term therapy. Acta Derm Venereol 1992; 72: 361–364
- Cash J. M., Swain M., Di Bisceglie A. M., Wilder R. L., Crofford L. J. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate. J Rheumatol 1992; 19: 1466–1468
- Scully C. J., Anderson C. J., Cannon G. W. Long‐term methotrexate therapy for rheumatoid arthritis. Semin Arthritis Rheum 1991; 20: 317–331
- Friedman S. L., Millward-Sadler G. H., Arthur M. J. P. Liver fibrosis and cirrhosis. Wright's Liver and Biliary Diseases, Millward-Sadler, et al. Saunders, Philadelphia 1994; 822–881
- Jaskiewicz K., Chasen M. R., Robson S. C. Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease. Anticancer Res 1993; 13: 2229–2237
- Drosos A. A., Psychos D., Andonopoulos A. P., et al. Methotrexate therapy in rheumatoid arthritis. A two year prospective follow‐up din Rheumatol 1990; 9: 333–341
- Willkens R. F., Leonard P. A., Clegg D. O., et al. Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis. Ann Rheum Dis 1990; 49: 591–593
- Jaskiewicz K., Robson S. C., Banach L. Toxic hepatic injury is associated with proliferation of portal nerve fibers. Pathol Res Pract 1993; 189: 1191–1194
- Jaskiewicz K., Voigt M. D., Robson S. C. Distribution of hepatic nerve fibers in liver diseases. Digestion 1994; 55: 247–252